drugset
Drugs / V212
last change Jul 2026 re-read 2 minutes ago

V212

also known as ZVIN

Vaccine

Developed for
herpes zoster
Investigated by
Merck Sharp & Dohme LLC · CR2O · Virometix

Trials 9 · a red edge is where a trial was stopped

today NCT06975319 · Ph 0 NCT02180295 · Ph 3 NCT01527383 · Ph 2 NCT01460719 · Ph 1 NCT01254630 · Ph 3 NCT01229267 · Ph 3 NCT00886613 · Ph 1 NCT00696709 · Ph 1 NCT00535236 · Ph 1
20082009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 01 trial
Phase 0 NCT06975319 Jan → Dec 2025 overdue — Virometix Active not recruiting No outcome recorded
Phase 14 trials
Phase 1 NCT01460719 Jan → Sep 2012 herpes zoster Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 1 NCT00886613 Mar → Dec 2009 herpes zoster Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 1 NCT00696709 Dec 2008 → Nov 2009 herpes zoster Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 1 NCT00535236 Nov 2007 → Jan 2010 herpes zoster Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 21 trial
Phase 2 NCT01527383 Feb 2012 → Feb 2013 herpes zoster Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 33 trials
Phase 3 NCT02180295 Jul 2014 → Mar 2015 herpes zoster Merck Sharp & Dohme LLC Withdrawn No outcome recorded
Phase 3 NCT01254630 Jun 2011 → Apr 2017 herpes zoster Merck Sharp & Dohme LLC Completed No outcome recorded
Phase 3 NCT01229267 Nov 2010 → Dec 2015 herpes zoster Merck Sharp & Dohme LLC Completed No outcome recorded

Evidence & citations 4 cited values

Every value below carries the sentence it was read from. 10 sources stand behind the page.

FieldValueCited text
Known as V212 ClinicalTrials.gov intervention name — accepted as the source's own label NCT01527383 ↗
8

NCT00696709 ↗

NCT01254630 ↗

NCT02180295 ↗

NCT01460719 ↗

NCT00886613 ↗

NCT00535236 ↗

NCT01229267 ↗

NCT06975319 ↗
Known as ZVIN “In phase 3 trials, inactivated varicella zoster virus (VZV) vaccine (ZVIN) was well tolerated and efficacious against herpes zoster (HZ)” PMID 32665955 ↗ Jun 2020
Modality Vaccine “V212/Heat-Treated Varicella-Zoster Virus (VZV) Vaccine” NCT00535236 ↗
Route Subcutaneous “0.65 mL subcutaneous injection of heat-treated varicella zoster virus (VZV) vaccine A” NCT00696709 ↗